The approach could enable 30-minute testing for a heart condition that is newly treatable following recent drug approvals.

Owner Zishan Alvi submitted claims for COVID-19 tests that were either never performed or were performed incorrectly, releasing potentially false negative test results to patients.

NEW YORK – Qiagen announced on Wednesday that it has launched a third-party partnering program for its clinical digital PCR platform and signed an agreement with the program's inaugural partner, South ...

Adding the firm's multi-cancer early detection test to standard-of-care screening demonstrated substantially greater additional cancer detection than in Pathfinder.

Caris plans to use the proceeds from its IPO to pay off about $400 million worth of debt, he noted, and it also intends to use the funds to drive toward profitability next year and continue expanding ...

NEW YORK — EDX Medical Group said on Monday that it has a signed a memorandum of understanding with UK-based healthcare group Spire Healthcare around diagnostic products and testing services. Spire ...

The firm said in May it was considering the surcharge following disclosure of a $40 million tariff-related headwind for 2025.

NEW YORK – Scope Biosciences has secured €1 million ($1.2 million) in follow-on investment to scale its molecular diagnostics platform. The diagnostics developer said Monday that the investment from ...

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

NEW YORK – French diagnostics developer BioMérieux announced Monday that it will acquire Day Zero Diagnostics' assets for approximately $25 million in a deal aimed at growing BioMérieux's position in ...